No idea and it’s not relevant. The issue there was, as I said, Germany had structured into their rules protectionist policies that such drugs must be manufactured in Germany, and likely this was just not practical to set-up. There likely was a range of various constraints like that and pertaining to that. They knew they could do the same thing in their own factory ultimately, without the hassle and cost, which we saw in Sawston, of setting up a licensed manufacturing facility. Germany looks like it thought maybe it could get them to set that up in Germany, but they were already moving along, with substantial investment, to doing so in the UK.
News 
Market Data 
Discover 
